Historical record - last NADAC effective date: 6/19/2024
Product Information
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB is a generic product labeled by Larken Laboratories, Inc., priced at $0.7692 per EA under NDC 68047072130. Its NADAC has been published 277 times since Mar 6, 2019.
FDA first approved this application on Dec 4, 2015. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 50 mg/1; mg/1
Manufacturer
Larken Laboratories, Inc.NDC
68047072130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
ACETAMINOPHEN; BUTALBITALApproval Type
Generic (ANDA)
FDA Application
ANDA203484FDA Approved
12/4/2015
TE Code
AA
On Market Since
12/4/2015
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has been published 277 times since Mar 6, 2019, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7692 per EA |
|---|---|
| All-time high | $1.1927 (Mar 13, 2019) |
| All-time low | $0.5829 (Aug 23, 2023) |
| Median price | $0.9283 |
| Average price | $0.9231 |
| Largest weekly change | +47.5% (Sep 21, 2022) |
| Weeks tracked | 277 |
| Tracking since | Mar 6, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-12.6%
5Y
+0.4%
All
-35.5%
Last surveyed Jun 19, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB, manufactured by Larken Laboratories, Inc., is $0.7692 per EA (NDC 68047072130), effective Jun 19, 2024.
How has the price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has declined 35.5%. It has been tracked across 277 weekly CMS publications since Mar 6, 2019.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
Since Mar 6, 2019, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has ranged from a low of $0.5829 (Aug 23, 2023) to a high of $1.1927 (Mar 13, 2019), with a median of $0.9283 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB, is $0.5892 per EA — about 23% below BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB.
Who manufactures BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB (NDC 68047072130) is labeled by Larken Laboratories, Inc., and CMS classifies it as a generic product.